BARCELONA, SPAIN— On the occasion of the 11th International Global Virus Network meeting, Aalto Bio Reagents launches the first commercially available protein for the detection and diagnosis of Venezuela Equine Encephalitis NSP2 TC83. Venezuela Equine Encephalitis is a mosquito-borne viral pathogen that causes Venezuela Equine Encephalitis or Encephalomyelitis (VEE). VEE can affect humans and animals alike causing flu-like […]

Latest release of enterprise software solution that enhances efficiency of biopharmaceutical development with special focus on supporting Multi-Attribute Methods (MAM) showcased at 2019 ASMS Atlanta, GA, USA Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist 13.0 at the 2019 ASMS Conference. The release streamlines mass […]

Chairman and CEO Kevin Hrusovsky to present at BIO and provide details about the HD-X launch and vision for continuing to pioneer disruption in healthcare with digital biomarkers Billerica, Mass. – Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, announced that it issued approximately 2.2 million […]

The new LUNARISTM Reader is a modern and compact state-of-the-art laboratory device designed to address the different needs in academic and industrial environments The availability of two models provides for flexibility by accommodating a range of standard low- to high-throughput formats with readout times of less than 10 minutes for 96 wells Easy-to-use “load and read” […]

ATLANTA – ASMS 2019 – Thermo Fisher Scientific, the world leader in serving science, and Evosep, a leading provider of sample preparation technologies for protein-based clinical research, have entered into a collaboration to develop high-throughput clinical research proteomics workflows for profiling large plasma sample cohorts for proteomics, translational research and pharmaceutical applications. Leveraging the advanced omics technologies offered […]

Thermo Fisher and Biognosys to develop industry-leading mass spectrometry-based workflows for the efficient analysis of proteins in complex biological matrices   ATLANTA – ASMS 2019 – Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation proteomics solutions, will extend their long-standing collaboration to provide advanced data independent acquisition (DIA) mass spectrometry-based […]

Innovative solutions integrate new data acquisition, analytical and smart algorithm capabilities   ATLANTA – ASMS 2019 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is accelerating the pace of innovation in the lab with the introduction of a new generation of intelligence-driven mass spectrometry instruments, workflows and software. The company will showcase […]

Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced commercial partnerships with three Contract Research Organizations (CROs), including Covance, NeoGenomics Laboratories, Inc., and Navigate BioPharma […]

World-class facility will offer the Company nearly three times the space for disruptive biomarker technology innovation and to accommodate growing pharma services business BILLERICA, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the relocation of its headquarters to a brand new, state-of-the-art facility in Billerica, […]

Today Genovis expands its portfolio of glycan specific enzymes with the launch of SialEXO 23. A new member of the SialEXO family, SialEXO 23 is an enzyme for study of a specific type of sugar on biopharmaceuticals. Most biopharmaceutical drugs are glycoproteins and the glycan composition is of interest to biopharma companies since it can impact the function and half-life of a particular therapeutic. The […]